
Lōkahi Therapeutics Expands ai2 Pipeline Program Through Pepperdine E2B Collaboration
Lōkahi Therapeutics Expands ai2 Pipeline Program Through Partnership With Pepperdine E2B Lōkahi Therapeutics™, a subsidiary of Glucotrack, Inc. (Nasdaq: GCTK), has announced a new collaboration with Pepperdine E2B™ (Education to Business) designed to connect graduate-level business education with real-world opportunities…














